phenazopyridine has been researched along with Pelvic Organ Prolapse in 1 studies
Phenazopyridine: A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
phenazopyridine : A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
Pelvic Organ Prolapse: Abnormal descent of a pelvic organ resulting in the protrusion of the organ beyond its normal anatomical confines. Symptoms often include vaginal discomfort, DYSPAREUNIA; URINARY STRESS INCONTINENCE; and FECAL INCONTINENCE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sierra, T | 1 |
Taylor, DL | 1 |
Leung, K | 1 |
Hall, CD | 1 |
Flynn, MK | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Phenazopyridine on Prolapse Surgery Voiding Trials[NCT03065075] | Phase 3 | 152 participants (Actual) | Interventional | 2017-02-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Rate of postoperative urinary retention after pelvic organ prolapse surgery as determined by those who failed a standardized void trial. A successful void trial is defined as a postvoid residual of less than half of the voided volume. (NCT03065075)
Timeframe: postoperative day 1
Intervention | Participants (Count of Participants) |
---|---|
Phenazopyridine | 28 |
No Phenazopyridine | 27 |
Rate of postoperative urinary retention after pelvic organ prolapse surgery as determined by those who failed a standardized void trial. A successful void trial is defined as a postvoid residual of less than half of the voided volume. (NCT03065075)
Timeframe: postoperative day 1
Intervention | Participants (Count of Participants) |
---|---|
Phenazopyridine | 30 |
No Phenazopyridine | 25 |
1 trial available for phenazopyridine and Pelvic Organ Prolapse
Article | Year |
---|---|
The Effect of Phenazopyridine on Immediate Postoperative Voiding After Prolapse Surgery: A Randomized Controlled Trial.
Topics: Anesthetics; Female; Humans; Middle Aged; Pelvic Organ Prolapse; Phenazopyridine; Postoperative Care | 2021 |